Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
Cancer Epidemiol Biomarkers Prev
    April 2024
  1. COLLISTER JA, Liu X, Littlejohns TJ, Cuzick J, et al
    Assessing the value of incorporating a polygenic risk score with non-genetic factors for predicting breast cancer diagnosis in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  2. MOSS JL, Geyer NR, Lengerich EJ
    Patterns of Cancer-Related Healthcare Access across Pennsylvania: Analysis of Novel Census Tract-Level Indicators of Persistent Poverty.
    Cancer Epidemiol Biomarkers Prev. 2024;33:616-623.
    >> Share

  3. BARBER LE, McCullough LE, Johnson DA
    Eyes Wide Open: Sleep as a Potential Contributor to Racial and Ethnic Disparities in Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024;33:471-479.
    >> Share

  4. HAN E, Van Horn L, Snetselaar L, Shepherd JA, et al
    The Associations between Intakes of One-Carbon Metabolism-Related Vitamins and Breast Density among Young Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:567-575.
    >> Share

    March 2024
  5. SIEGEL SD, Zhang Y, Lynch SM, Rowland J, et al
    A Novel Approach for Conducting a Catchment Area Analysis of Breast Cancer by Age and Stage for a Community Cancer Center.
    Cancer Epidemiol Biomarkers Prev. 2024 Mar 7. doi: 10.1158/1055-9965.EPI-23-1125
    >> Share

  6. LEE M, Kotake R, Yamauchi H
    Physical Activity and Mammographic Density in Japanese Women.
    Cancer Epidemiol Biomarkers Prev. 2024;33:365-370.
    >> Share

    February 2024
  7. FARBER R, Houssami N, McGeechan K, Barratt A, et al
    Breast cancer stage and size detected with film versus digital mammography in New South Wales, Australia: a population-based study using routinely collected data.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  8. ANDERSEN HH, Bojesen SE, Johansen JS, Ejlertsen B, et al
    Prognostic Value of Pre-treatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  9. UONG SP, Torres JM, Alexeeff SE, Morey BN, et al
    Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among Women Diagnosed with Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

  10. DEVASIA TP, Howlader N, Dewar RA, Stevens JL, et al
    Increase in the Life Expectancy of Patients with Cancer in the United States.
    Cancer Epidemiol Biomarkers Prev. 2024;33:196-205.
    >> Share

  11. PEILA R, Rohan TE
    Metabolic Syndrome and the Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2024;33:333-336.
    >> Share

    January 2024
  12. ZELDIN J, Sandler DP, Ogunsina K, O'Brien KM, et al
    Association of fibroids, endometriosis, and gynecologic surgeries with breast cancer incidence and hormone receptor subtypes.
    Cancer Epidemiol Biomarkers Prev. 2024.
    >> Share

    December 2023
  13. AIELLO BOWLES EJ, Kroenke CH, Chubak J, Bhimani J, et al
    Evaluation of algorithms using automated health plan data to identify breast cancer recurrences.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

  14. GARDUNO-ALANIS A, Angeles-Llerenas A, Sanchez-Zamorano LM, Flores-Luna L, et al
    Sugar-sweetened beverage consumption and breast cancer in pre- and post-menopausal women.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

  15. YE Z, Dite GS, Nguyen TL, Maclnnis RJ, et al
    Genetic and environmental causes of variation in an automated breast cancer risk factor based on mammographic textures.
    Cancer Epidemiol Biomarkers Prev. 2023 Dec 7. doi: 10.1158/1055-9965.EPI-23-1012
    >> Share

  16. TRAN TXM, Kim S, Park B
    Mammographic Breast Density and Risk of Ovarian Cancer in Korean Women.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1690-1698.
    >> Share

  17. HODGE JM, Patel AV, Islami F, Jemal A, et al
    Educational Attainment and Cancer Incidence in a Large Nationwide Prospective Cohort.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1747-1755.
    >> Share

    November 2023
  18. LORONA NC, Othus M, Malone KE, Linden HM, et al
    Alcohol, smoking, and risks of breast cancer recurrence and mortality among women with luminal, triple-negative, and HER2-overexpressing breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

  19. LORD SJ, Daniels B, O'Connell DL, Kiely BE, et al
    Decline in the incidence of distant recurrence of breast cancer: A population-based health record linkage study, Australia 2001-2016.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

  20. GOLDFINGER E, Stoler J, Goel N
    A multi-scale space-time epidemiological analysis of neighborhood correlates of triple negative breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

  21. PETERS BA, Kelly L, Wang T, Loudig O, et al
    The breast microbiome in breast cancer risk and progression: a narrative review.
    Cancer Epidemiol Biomarkers Prev. 2023 Nov 9. doi: 10.1158/1055-9965.EPI-23-0965
    >> Share

  22. TEHRANIFAR P, Bertrand KA
    Enhancing Mammography and Empowering Solutions for Breast Cancer Disparities.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1479-1481.
    >> Share

  23. CHATTERJEE N, Dun Y
    From Hazard Rate to Age-at-Onset Distribution: Mind the Gap.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1477-1478.
    >> Share

  24. NYANTE SJ, Abraham L, Aiello Bowles EJ, Lee CI, et al
    Racial and Ethnic Variation in Diagnostic Mammography Performance among Women Reporting a Breast Lump.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1542-1551.
    >> Share

  25. HUBBARD RA, Pujol TA, Alhajjar E, Edoh K, et al
    Sources of Disparities in Surveillance Mammography Performance and Risk-Guided Recommendations for Supplemental Breast Imaging: A Simulation Study.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1531-1541.
    >> Share

  26. KERLIKOWSKE K, Bissell MCS, Sprague BL, Tice JA, et al
    Impact of BMI on Prevalence of Dense Breasts by Race and Ethnicity.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1524-1530.
    >> Share

    October 2023
  27. HASHIBE M, Wei M, Lee CJ, Tao R, et al
    Incident Cardiovascular Disease Risk Among Older Asian, Native Hawaiian and Pacific Islander Breast Cancer Survivors.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

  28. KOTSOPOULOS J, Hathaway CA, Narod SA, Teras LR, et al
    Germline Mutations in 12 Genes and Risk of Ovarian Cancer in Three Population-Based Cohorts.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1402-1410.
    >> Share

  29. KEHM RD, Lilge L, Walter EJ, White M, et al
    Socioeconomic Status at Birth and Breast Tissue Composition in Adolescence and Adulthood.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1294-1301.
    >> Share

    September 2023
  30. ERGAS IJ, Bradshaw PT, Cespedes Feliciano EM, Roh JM, et al
    Hypothetical interventions on diet quality and lifestyle factors to improve breast cancer survival: the Pathways Study.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

  31. MARIOTTO AB, Botta L, Bernasconi A, Zou Z, et al
    Prediction of risk of metastatic recurrence for female breast cancer patients in the presence of competing causes of death.
    Cancer Epidemiol Biomarkers Prev. 2023.
    >> Share

    August 2023
  32. KAUR M, Patterson A, Molina-Vega J, Rothschild H, et al
    Area Deprivation Index in Patients with Invasive Lobular Carcinoma of the Breast: Associations with Tumor Characteristics and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2023;32:1107-1113.
    >> Share

    July 2023
  33. KORIC A, Mark B, Chang CP, Lloyd S, et al
    Adverse Health Outcomes Among Rural And Urban Breast Cancer Survivors: A Population-Based Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jul 18:EPI-23-0421.
    >> Share

  34. HERBACH EL, Nash SH, Lizarraga IM, Carnahan RM, et al
    Patterns of evidence-based care for the diagnosis, staging, and first-line treatment of breast cancer by race-ethnicity: a SEER-Medicare study.
    Cancer Epidemiol Biomarkers Prev. 2023 Jul 12:EPI-23-0218.
    >> Share

    June 2023
  35. CHOI J, Ha TW, Choi HM, Lee HB, et al
    Development of a breast cancer risk prediction model incorporating polygenic risk scores and non-genetic risk factors for Korean women.
    Cancer Epidemiol Biomarkers Prev. 2023 Jun 13:EPI-23-0064.
    >> Share

    April 2023
  36. TROESCHEL AN, Hartman TJ, McCullough LE, Ergas IJ, et al
    Associations of post-diagnosis lifestyle with prognosis in women with invasive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2023 Apr 20:EPI-22-1274.
    >> Share

    March 2023
  37. MEYER DS, Millen AE, Nie J, Trevisan M, et al
    Dietary fats and all-cause and breast cancer specific mortality among women with breast cancer: The Western New York Exposures and Breast Cancer (WEB) Study.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 30:EPI-22-0881.
    >> Share

  38. LOU MW, Drummond AE, Swain CT, Milne RL, et al
    Linking physical activity to breast cancer via inflammation, Part 2: The effect of inflammation on breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 3:EPI-22-0929.
    >> Share

  39. SWAIN CT, Drummond AE, Milne RL, English DR, et al
    Linking physical activity to breast cancer risk via inflammation, Part 1: The effect of physical activity on inflammation.
    Cancer Epidemiol Biomarkers Prev. 2023 Mar 3:EPI-22-0928.
    >> Share

    February 2023
  40. MUSE ME, Carroll CD, Salas LA, Karagas MR, et al
    Application of novel breast biospecimen cell type adjustment identifies shared DNA methylation alterations in breast tissue and milk with breast cancer risk factors.
    Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-0405.
    >> Share

  41. JOHN EM, Koo J, Ingles SA, Kurian AW, et al
    Changes in breast cancer risk and risk factor profiles among U.S.-born and immigrant Asian American women residing in the San Francisco Bay Area.
    Cancer Epidemiol Biomarkers Prev. 2023 Feb 10:EPI-22-1128.
    >> Share

  42. ROSENZWEIG MQ, Mazanec SR
    Racial Differences in Breast Cancer Therapeutic Toxicity: Implications for Practice.
    Cancer Epidemiol Biomarkers Prev. 2023;32:157-158.
    >> Share

  43. DE HAAN-DU J, Groenier KH, Wauben-Spaetgens B, Jalving M, et al
    The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care.
    Cancer Epidemiol Biomarkers Prev. 2023;32:252-259.
    >> Share

    January 2023
  44. SU YR, Buist DS, Lee JM, Ichikawa L, et al
    Performance of statistical and machine learning risk prediction models for surveillance benefits and failures in breast cancer survivors.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 25:EPI-22-0677.
    >> Share

  45. YASUI Y, Letsou W, Wang F, Im C, et al
    Inference on the Genetic Architecture of Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 18:EPI-22-1073.
    >> Share

  46. MAVADDAT N, Ficorella L, Carver T, Lee A, et al
    Incorporating alternative Polygenic Risk Scores into the BOADICEA breast cancer risk prediction model.
    Cancer Epidemiol Biomarkers Prev. 2023 Jan 13:EPI-22-0756.
    >> Share

    December 2022
  47. NARII N, Kito K, Sobue T, Zha L, et al
    Acrylamide and glycidamide hemoglobin adduct levels and breast cancer risk in Japanese women: A nested case-control study in the JPHC.
    Cancer Epidemiol Biomarkers Prev. 2022 Dec 16:EPI-22-0904.
    >> Share

  48. SWAIN CTV, Drummond AE, Milne RL, English DR, et al
    Linking Physical Activity to Breast Cancer Risk via Insulin/Insulin-Like Growth Factor Signaling System, Part 1: The Effect of Physical Activity on the Insulin/Insulin-Like Growth Factor Signaling System.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2106-2115.
    >> Share

  49. DRUMMOND AE, Swain CTV, Milne RL, English DR, et al
    Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2116-2125.
    >> Share

    November 2022

  50. Correction: Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2092.
    >> Share

  51. DUCHESNEAU ED, Jackson BE, Webster-Clark M, Lund JL, et al
    The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.
    Cancer Epidemiol Biomarkers Prev. 2022;31:2079-2086.
    >> Share

    October 2022
  52. MACCIOTTA A, Catalano A, Giraudo MT, Weiderpass E, et al
    Mediating role of lifestyle behaviours in the association between education and cancer: results from the European Prospective Investigation into Cancer and Nutrition.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 28. pii: 710109.
    >> Share

  53. HVIDTFELDT UA, Chen J, Rodopoulou S, Strak M, et al
    Breast cancer incidence in relation to long-term low-level exposure to air pollution in the ELAPSE pooled cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 10. pii: 709688.
    >> Share

  54. ASHI K, Ndom P, Gakwaya A, Makumbi T, et al
    Validation of the Nigerian Breast Cancer Study Model for Predicting Individual Breast Cancer Risk in Cameroon and Uganda.
    Cancer Epidemiol Biomarkers Prev. 2022 Oct 10. pii: 709687.
    >> Share

    September 2022
  55. HU X, Kaplan CM, Martin MY, Walker MS, et al
    Race differences in patient-reported symptoms during chemotherapy among women with early-stage hormone receptor positive breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 27. pii: 709495.
    >> Share

  56. WALENS A, Van Alsten SC, Olsson LT, Smith MA, et al
    RNA-based classification of homologous recombination deficiency in racially-diverse patients with breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 21. pii: 709340.
    >> Share

  57. CROSS T, George A, Attwood K, Zhang Y, et al
    Associations between Serum 25-hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Breast Cancer Patients: A Longitudinal Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 20. pii: 709294.
    >> Share

  58. YE H, Tang LY, Liang ZZ, Chen QX, et al
    Effects of infection-induced fever and the interaction with interleukin-6 rs1800796 polymorphism on the prognosis of breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Sep 9. pii: 709164.
    >> Share

  59. BAZAN JG, Obeng-Gyasi S
    Disparities in Early-Stage Breast Cancer and Survival-Letter.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1867.
    >> Share

  60. PRIMM KM, Zhao H, Hernandez DC, Chang S, et al
    Disparities in Early-Stage Breast Cancer and Survival-Reply.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1868.
    >> Share

    August 2022
  61. OLSSON LT, Walens A, Hamilton AM, Fleming JM, et al
    Obesity and Breast Cancer Metastasis Across Genomic Subtypes.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 16. pii: 707899.
    >> Share

  62. WANG T, Heng YJ, Baker GM, Bret-Mounet VC, et al
    Loss of PTEN Expression, PIK3CA Mutations, and Breast Cancer Survival in the Nurses' Health Studies.
    Cancer Epidemiol Biomarkers Prev. 2022 Aug 1. pii: 707366.
    >> Share

    July 2022
  63. KORN AR, Reedy J, Brockton NT, Kahle LL, et al
    The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and cancer risk: a longitudinal analysis in the NIH-AARP Diet and Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 25. pii: 707213.
    >> Share

  64. WALLNER LP, Chen LH, Hogan TA, Brasfield FM, et al
    The influence of medical comorbidities on survival disparities in a multi-ethnic group of patients with de novo metastatic breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2022 Jul 21. pii: 707116.
    >> Share

  65. NORMANN AJ, Kang DW, Christopher CN, Norris MK, et al
    Improved Sleep Quality Is Associated with Reduced Insulin Resistance in Cancer Survivors Undertaking Circuit, Interval-Based Exercise.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1509-1510.
    >> Share

  66. BENASHLEY LW, Bucy AM, Wertheim BC, Blew R, et al
    Paclitaxel Treatment Effects on Neurofilament Light Chain (NF-L), a Possible Biomarker of Chemotherapy-Induced Peripheral Neuropathy (CIPN).
    Cancer Epidemiol Biomarkers Prev. 2022;31:1510-1511.
    >> Share

  67. BALLINGER TJ, Djuric Z, Sardesai S, Hovey K, et al
    Proton Pump Inhibitor Use and Obesity-Associated Cancers in the Women's Health Initiative.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1511.
    >> Share

  68. LECOMPTE CG, McDougall J, Walters ST, Toppmeyer D, et al
    Understanding Cancer Genetic Risk Assessment Intentions in a Tailored Risk Communication Intervention Randomized Controlled Trial.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1513-1514.
    >> Share

  69. BELLISSIMO MP, Canada JM, Jordan JH, Ladd AC, et al
    Changes in Physical Activity, Functional Capacity, and Cardiac Function during Breast Cancer Therapy.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1509.
    >> Share

  70. NYANTE SJ, Abraham L, Aiello Bowles EJ, Lee CI, et al
    Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1324-1333.
    >> Share

  71. BARNARD ME, Martheswaran T, Van Meter M, Buys SS, et al
    Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1313-1323.
    >> Share

  72. LESSER C, Mericq V, Reyes M, Garmendia ML, et al
    Habitual Phytoestrogen Intake Is Associated with Breast Composition in Girls at 2 Years after Menarche Onset.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1334-1340.
    >> Share

  73. PEILA R, Rohan TE
    Association of Prediagnostic Serum Levels of Vitamin D with Risk of Ductal Carcinoma In Situ of the Breast in the UK Biobank Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1499-1502.
    >> Share

    June 2022
  74. AHEARN TU, Pal Choudhury P, Derkach A, Wiafe-Addai B, et al
    Breast cancer risk in women from Ghana carrying rare germline pathogenic mutations.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699329.
    >> Share

  75. ROSNER B, Glynn RJ, Eliassen AH, Hankinson SE, et al
    A multi-state survival model for time to breast cancer mortality among a cohort of initially disease-free women.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699326.
    >> Share

  76. ZAVALA VA, Casavilca-Zambrano S, Navarro Vasquez J, Castaneda CA, et al
    Association between ancestry-specific 6q25 variants and breast cancer subtypes in Peruvian women.
    Cancer Epidemiol Biomarkers Prev. 2022 Jun 2. pii: 699327.
    >> Share

  77. BRADLEY CJ, Sabik LM, Entwistle J, Stevens JL, et al
    Role of Medicaid in Early Detection of Screening-Amenable Cancers.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1202-1208.
    >> Share

    May 2022
  78. MCWILLIAMS L, Groves S, Howell SJ, French DP, et al
    The impact of morbidity and disability on attendance at organised breast cancer screening programmes: A systematic review and meta-analysis.
    Cancer Epidemiol Biomarkers Prev. 2022 May 5. pii: 696307.
    >> Share

  79. MENDOZA JA, Miller CA, Martin KJ, Resnicow K, et al
    Examining the Association of Food Insecurity and Being Up-to-Date for Breast and Colorectal Cancer Screenings.
    Cancer Epidemiol Biomarkers Prev. 2022;31:1017-1025.
    >> Share

    April 2022
  80. KOTSOPOULOS J, Lubinski J, Gronwald J, Menkiszak J, et al
    Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 27. pii: 694788.
    >> Share

  81. HAMILTON AM, Hurson AN, Olsson LT, Walens A, et al
    The landscape of immune microenvironments in racially-diverse breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2022 Apr 18. pii: 694482.
    >> Share

  82. WANG X, Cho-Phan CD, Hoskins KF, Calip GS, et al
    Understanding Racial and Ethnic Inequities in Uptake and Outcomes Following Multigene Prognostic Testing in Early Breast Cancer: The Promise of Real-World Data.
    Cancer Epidemiol Biomarkers Prev. 2022;31:704-706.
    >> Share

    March 2022
  83. PRIMM KM, Zhao H, Hernandez DC, Chang S, et al
    A contemporary analysis of racial and ethnic disparities in diagnosis of early stage breast cancer and stage-specific survival by molecular subtype.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 21. pii: 682328.
    >> Share

  84. PALA V, Agnoli C, Cavalleri A, Rinaldi S, et al
    Pre-diagnostic levels of copper and zinc and breast cancer risk in the ORDET cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 4. pii: 682049.
    >> Share

  85. NGUYEN SM, Tran HT, Nguyen LM, Bui OT, et al
    Association of fruit, vegetable and animal food intakes with breast cancer risk overall and by molecular subtype among Vietnamese women.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 3. pii: 682000.
    >> Share

  86. MCDONALD JA, Vilfranc CL, Terry MB
    The Epidemiology of Pregnancy-Related Breast Cancers: Are We Ready to Deliver?
    Cancer Epidemiol Biomarkers Prev. 2022;31:518-520.
    >> Share

  87. HASLAM DE, John EM, Knight JA, Li Z, et al
    Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry.
    Cancer Epidemiol Biomarkers Prev. 2022 Mar 1:EPI-22-1198.
    >> Share

    February 2022
  88. HOLDER EX, Houghton SC, Sanchez SS, Eliassen AH, et al
    Estrogenic activity and risk of invasive breast cancer among postmenopausal women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Feb 7. pii: 1055-9965.EPI-21-1157.
    >> Share

    January 2022
  89. MOORE J, Wang F, Pal T, Reid S, et al
    Oncotype DX Risk Recurrence Score and Total Mortality for Early-Stage Breast Cancer by Race/Ethnicity.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-0929.
    >> Share

  90. BRANTLEY KD, Zeleznik OA, Rosner B, Tamimi RM, et al
    Plasma Metabolomics and Breast Cancer Risk Over 20 Years of Follow-up Among Postmenopausal Women in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 21. pii: 1055-9965.EPI-21-1023.
    >> Share

  91. STRANDBERG R, Czene K, Eriksson M, Hall P, et al
    Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort.
    Cancer Epidemiol Biomarkers Prev. 2022 Jan 13. pii: 1055-9965.EPI-21-1011.
    >> Share

  92. NAIR RG, Lee SJC, Berry E, Argenbright KE, et al
    Long-term Mammography Adherence among Uninsured Women Enrolled in the Breast Screening and Patient Navigation (BSPAN) Program.
    Cancer Epidemiol Biomarkers Prev. 2022;31:77-84.
    >> Share

    December 2021
  93. PEILA R, Arthur RS, Dannenberg AJ, Rohan TE, et al
    Association of a healthy lifestyle index with risk of breast cancer among women with normal body mass index in the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 21. pii: 1055-9965.EPI-21-0765.
    >> Share

  94. NIEHOFF NM, Terry MB, Bookwalter DB, Kaufman JD, et al
    Air pollution and breast cancer: an examination of modification by underlying familial breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 14. pii: 1055-9965.EPI-21-1140.
    >> Share

  95. CONNOR AE, Kaur M, Dibble KE, Visvanathan K, et al
    Racialized economic segregation and breast cancer mortality among women in Maryland.
    Cancer Epidemiol Biomarkers Prev. 2021 Dec 3. pii: 1055-9965.EPI-21-0923.
    >> Share

  96. TIN TIN S, Key TJ, Reeves GK
    Alcohol Intake and Endogenous Hormones in Pre- and Postmenopausal Women: Findings from the UK Biobank.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2294-2301.
    >> Share

    November 2021
  97. VOHRA SN, Walens A, Hamilton AM, Sherman ME, et al
    Molecular and clinical characterization of postpartum-associated breast cancer in the Carolina Breast Cancer Study Phase I-III, 1993-2013.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0940.
    >> Share

  98. NAZARIO CM, Rosario-Rosado RV, Schelske-Santos M, Mansilla-Rivera I, et al
    Sun exposure is associated with reduced breast cancer risk among women living in the Caribbean: The Atabey study in Puerto Rico.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 22. pii: 1055-9965.EPI-21-0932.
    >> Share

  99. CHARVAT H, Freisling H, Noh H, Gaudet MM, et al
    Excess body fatness during early to mid-adulthood and survival from colorectal and breast cancer: a pooled analysis of five international cohort studies.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 15. pii: 1055-9965.EPI-21-0688.
    >> Share

  100. SIEGEL SD, Brooks MM, Sims-Mourtada J, Schug ZT, et al
    A Population Health Assessment in a Community Cancer Center Catchment Area: Triple negative breast cancer, alcohol use, and obesity in New Castle County, Delaware.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 4. pii: 1055-9965.EPI-21-1031.
    >> Share

  101. HURSON AN, Abubakar M, Hamilton AM, Conway K, et al
    TP53 pathway function, estrogen receptor status, and breast cancer risk factors in the Carolina Breast Cancer Study.
    Cancer Epidemiol Biomarkers Prev. 2021 Nov 4. pii: 1055-9965.EPI-21-0661.
    >> Share

  102. MARIOTTO AB, Zhang F, Buckman DW, Miller D, et al
    Characterizing Trends in Cancer Patients' Survival Using the JPSurv Software.
    Cancer Epidemiol Biomarkers Prev. 2021;30:2001-2009.
    >> Share

    October 2021
  103. DONG W, Bensken WP, Kim U, Rose J, et al
    Phenotype Discovery and Geographic Disparities of Late-Stage Breast Cancer Diagnosis across U.S. Counties: A Machine Learning Approach.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0838.
    >> Share

  104. PENG C, Zeleznik OA, Shutta KH, Rosner BA, et al
    A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0837.
    >> Share

  105. ZHANG X, Wolff MS, Shen J, Parada H, et al
    Phthalates and Phenols, Leukocyte Telomere Length, and Breast Cancer Risk and Mortality in the Long Island Breast Cancer Study Project.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 25. pii: 1055-9965.EPI-21-0830.
    >> Share

  106. LYNCH BM, Milne RL, English DR, Brown KA, et al
    Linking physical activity to breast cancer: text mining results and a protocol for systematically reviewing three potential mechanistic pathways.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0435.
    >> Share

  107. DRUMMOND AE, Swain CTV, Brown KA, Dixon-Suen SC, et al
    Linking physical activity to breast cancer via sex steroid hormones Part 2: The effect of sex steroid hormones on breast cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0438.
    >> Share

  108. SWAIN CTV, Drummond AE, Boing L, Milne RL, et al
    Linking physical activity to breast cancer via sex hormones part 1: The effect of physical activity on sex steroid hormones.
    Cancer Epidemiol Biomarkers Prev. 2021 Oct 20. pii: 1055-9965.EPI-21-0437.
    >> Share

    September 2021
  109. TAN VY, Bull CJ, Biernacka KM, Teumer A, et al
    Investigation of the interplay between circulating lipids and IGF-I and relevance to breast cancer risk: an observational and Mendelian randomization study.
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. pii: 1055-9965.EPI-21-0315.
    >> Share

  110. OMOFUMA OO, Peterson LL, Turner DP, Merchant AT, et al
    Dietary Advanced Glycation End-Products (AGEs) and Mortality After Breast Cancer in the Women's Health Initiative (WHI).
    Cancer Epidemiol Biomarkers Prev. 2021 Sep 28. pii: 1055-9965.EPI-21-0610.
    >> Share

    August 2021
  111. BARON JA, Nichols HB, Anderson C, Safe S, et al
    Cigarette Smoking and Estrogen-Related Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021;30:1462-1471.
    >> Share

    June 2021
  112. PEILA R, Chlebowski R, Manson JE, Crane TE, et al
    Low-fat dietary modification and risk of ductal carcinoma in situ of the breast in the Women's Health Initiative Dietary Modification trial.
    Cancer Epidemiol Biomarkers Prev. 2021 Jun 29. pii: 1055-9965.EPI-21-0404.
    >> Share

    May 2021
  113. DIMOU N, Yarmolinsky J, Bouras E, Tsilidis KK, et al
    Causal Effects of Lifetime Smoking on Breast and Colorectal Cancer Risk: Mendelian Randomization Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:953-964.
    >> Share

  114. WILSON LF, Tuesley KM, Webb PM, Dixon-Suen SC, et al
    Hysterectomy and Risk of Breast, Colorectal, Thyroid, and Kidney Cancer - an Australian Data Linkage Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:904-911.
    >> Share

    April 2021
  115. SHEPPARD VB, Sutton AL, Hurtado-de-Mendoza A, He J, et al
    Race and Patient-reported Symptoms in Adherence to Adjuvant Endocrine Therapy: A Report from the Women's Hormonal Initiation and Persistence Study.
    Cancer Epidemiol Biomarkers Prev. 2021;30:699-709.
    >> Share

    March 2021
  116. CARVER T, Hartley S, Lee A, Cunningham AP, et al
    CanRisk Tool-A Web Interface for the Prediction of Breast and Ovarian Cancer Risk and the Likelihood of Carrying Genetic Pathogenic Variants.
    Cancer Epidemiol Biomarkers Prev. 2021;30:469-473.
    >> Share

    January 2021
  117. BENEFIELD HC, Zirpoli GR, Allott EH, Shan Y, et al
    Epidemiology of Basal-like and Luminal Breast Cancers among Black Women in the AMBER Consortium.
    Cancer Epidemiol Biomarkers Prev. 2021;30:71-79.
    >> Share

  118. SPRAGUE BL, Vacek PM, Mulrow SE, Evans MF, et al
    Collagen Organization in Relation to Ductal Carcinoma In Situ Pathology and Outcomes.
    Cancer Epidemiol Biomarkers Prev. 2021;30:80-88.
    >> Share

    August 2020
  119. GAGLIARDI A, Dugue PA, Nost TH, Southey MC, et al
    Stochastic epigenetic mutations are associated with risk of breast cancer, lung cancer and mature B-cell neoplasms.
    Cancer Epidemiol Biomarkers Prev. 2020 Aug 11. pii: 1055-9965.EPI-20-0451.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016